FDA Adverse Event Injury Summary report: Y

LATERA ABSORBABLE NASAL 2 IMPLANTS GEN 1

MDR report key: 11878038 · Received May 25, 2021

Report

Report Number
3006345872-2021-00005
Event Type
Injury
Date Received
May 25, 2021
Date of Event
April 8, 2021
Report Date
August 30, 2021
Manufacturer
ENTELLUS MEDICAL, INC.
Product Code
NHB
PMA / PMN Number
K161191
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION RECEIVED ON MAY 13, 2021 INDICATES A BILATERAL REMOVAL WAS PERFORMED ON (B)(6) 2021. A PATHOLOGY REPORT WAS SUBMITTED THAT NOTES A PATHOLOGIC DIAGNOSIS OF NASAL SIDE WALLS LEFT AND RIGHT BIOPSY FOUND BENIGN SKIN WITH FRAGMENTS OF FIBROUS TISSUE AND NON-POLARIZABLE FOREIGN MATERIAL ASSOCIATED WITH GRANULOMATOUS/FOREIGN BODY GIANT CELL REACTION. THE IMPLANT WAS NOT RETURNED TO ENTELLUS MEDICAL FOR TESTING. THE PATHOLOGY TESTING WAS PERFORMED IN THE FIELD BY THE HOSPITAL.

Description of Event or Problem · 0

IT WAS REPORTED THE LATERA IMPLANTS WERE BILATERALLY PLACED ON (B)(6) 2018 DURING A SEPTOPLASTY AND TURBINATE REDUCTION PROCEDURE. ON (B)(6) 2021 THE PATIENT REPORTED BILATERAL IMPLANTS ARE VISIBLE AND MIGRATING TOWARD SKIN SURFACE AND APPEAR TO BE STARTING TO EXTRUDE THROUGH THE SKIN. ADDITIONAL INFORMATION RECEIVED ON (B)(6) 2021 INDICATES A BILATERAL REMOVAL WAS PERFORMED ON (B)(6) 2021. A PATHOLOGY REPORT WAS SUBMITTED THAT NOTES A PATHOLOGIC DIAGNOSIS OF NASAL SIDE WALLS LEFT AND RIGHT BIOPSY FOUND BENIGN SKIN WITH FRAGMENTS OF FIBROUS TISSUE AND NON-POLARIZABLE FOREIGN MATERIAL ASSOCIATED WITH GRANULOMATOUS/FOREIGN BODY GIANT CELL REACTION.

Additional Manufacturer Narrative · 1

DEVICE WAS NOT RETURNED FOR ANALYSIS.

Description of Event or Problem · 1

IT WAS REPORTED THE LATERA IMPLANTS WERE BILATERALLY PLACED ON (B)(6) 2018 DURING A SEPTOPLASTY AND TURBINATE REDUCTION PROCEDURE. ON (B)(6) 2021 THE PATIENT REPORTED BILATERAL IMPLANTS ARE VISIBLE AND MIGRATING TOWARD SKIN SURFACE AND APPEAR TO BE STARTING TO EXTRUDE THROUGH THE SKIN. ADDITIONAL INFORMATION RECEIVED ON (B)(6) 2021 INDICATES A BILATERAL REMOVAL WAS PERFORMED ON (B)(6) 2021. A PATHOLOGY REPORT WAS SUBMITTED THAT NOTES A PATHOLOGIC DIAGNOSIS OF NASAL SIDE WALLS LEFT AND RIGHT BIOPSY FOUND BENIGN SKIN WITH FRAGMENTS OF FIBROUS TISSUE AND NON-POLARIZABLE FOREIGN MATERIAL ASSOCIATED WITH GRANULOMATOUS/FOREIGN BODY GIANT CELL REACTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
774334 LATERA ABSORBABLE NASAL 2 IMPLANTS GEN 1 NHB, LATERA ABSORBABLE NASAL NHB ENTELLUS MEDICAL, INC. 204641

Patients

Seq Age Sex Outcome Treatment
1 Other| R